Primary cilia promote resistance to EGFR tyrosine kinase inhibitor, osimertinib, in non–small cell lung cancer
Preprint
Abstract
Patients with advanced non–small cell lung cancer (NSCLC) and mutations in epidermal growth factor receptor (EGFR) benefit from EGFR tyrosine kinase inhibitors (TKIs). Osimertinib, a third-generation EGFR TKI, is standard first-line therapy for EGFR-mutated NSCLC, but most patients develop resistance to it. Here, we demonstrate that increased formation of primary cilia, microtubule-based sensory organelles, is associated with osimertinib-refractory NSCLC progression. EGFR-mutated, osimertinib-resistant human NSCLC cells had increased cilia formation and acetylation of α-tubulin and reduced histone deacetylase 6 (HDAC6) activity compared to their osimertinib-sensitive counterparts. HDAC6 inhibition increases cilia formation in osimertinib-sensitive NSCLC cells, and overexpression of exogenous HDAC6 sensitized osimertinib-resistant NSCLC cells to osimertinib’s anti-proliferative effects. Because intraflagellar transport (IFT) proteins are essential for primary cilium formation and function, we knocked down IFT88 in osimertinib-resistant NSCLC cells, which reversed osimertinib resistance in orthotopic and subcutaneous mouse models of lung cancer. Mechanistically, increased sodium influx during osimertinib-induced inhibition of EGFR signalling promotes cilia formation through sustained HDAC6 inactivity and greater α-tubulin acetylation. Inhibition of sodium influx with dibutyryl-cAMP decreased cilium formation, increased sensitivity to osimertinib, and reduced tumor progression in mice bearing osimertinib-resistant lung tumors. Collectively, our findings suggest that enhanced primary cilium formation mediates EGFR TKI resistance and that targeted inhibition of ciliogenesis may prevent or overcome osimertinib resistance.Keywords
Funding Information
- The Hormel Institute Internal Grants Program (Paint the Town Pink Award)
- National Institutes of Health (R01DK13281)
This publication has 61 references indexed in Scilit:
- N6‐Methyladenosine Regulates Cilia Elongation in Cancer Cells by Modulating HDAC6 ExpressionAdvanced Science, 2024
- ERRα contributes to HDAC6-induced chemoresistance of osteosarcoma cellsCell Biology and Toxicology, 2021
- Functional aspects of primary cilium in signaling, assembly and microenvironment in cancerJournal of Cellular Physiology, 2020
- MicroRNA (miR)‐433 and miR‐22 dysregulations induce histone‐deacetylase‐6 overexpression and ciliary loss in cholangiocarcinomaHepatology, 2018
- Detection of primary cilia in human glioblastomaJournal of Neuro-Oncology, 2014
- IFT88 Plays a Cilia- and PCP-Independent Role in Controlling Oriented Cell Divisions during Vertebrate Embryonic DevelopmentCell Reports, 2013
- Epigenetics and autosomal dominant polycystic kidney diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Primary cilia and coordination of receptor tyrosine kinase (RTK) signallingThe Journal of Pathology, 2011
- The Oak Ridge Polycystic Kidney mouse: Modeling ciliopathies of mice and menDevelopmental Dynamics, 2008
- cAMP regulates nitric oxide production and ouabain sensitive Na + , K + -ATPase activity in SH-SY5Y human neuroblastoma cellsDiabetologia, 1998